XML 18 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Operating Activities:    
Net Income Attributable to Kadant $ 24,344 $ 24,004
Net income attributable to noncontrolling interest 318 232
Income from discontinued operation (3) (56)
Income from continuing operations 24,659 24,180
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 10,934 8,247
Stock-based compensation expense 3,865 4,495
Tax benefits from stock-based compensation awards 0 (875)
Provision for losses on accounts receivable 420 205
(Gain) loss on the sale of property, plant, and equipment (384) 3
Other items, net 256 (91)
Contributions to pension plan (810) (810)
Changes in current assets and liabilities, net of effects of acquisition:    
Accounts receivable 3,731 (2,052)
Unbilled contract costs and fees 1,713 (2,601)
Inventories 2,051 (16,045)
Other current assets 620 (1,529)
Accounts payable (5,599) 813
Other current liabilities (6,717) 14,140
Net cash provided by continuing operations 34,739 28,080
Net cash used in discontinued operation (2) (36)
Net cash provided by operating activities 34,737 28,044
Investing Activities:    
Acquisition, net of cash acquired (56,617) 0
Purchases of property, plant, and equipment (3,579) (4,068)
Proceeds from sale of property, plant, and equipment 409 33
Net cash used in investing activities (59,787) (4,035)
Financing Activities:    
Proceeds from issuance of long-term obligations 48,046 20,000
Repayments of short- and long-term obligations (15,429) (16,486)
Purchases of Company common stock 0 (8,920)
Dividends paid (5,964) (5,346)
Tax withholding payments related to stock-based compensation (2,572) (2,499)
Payment of contingent consideration (1,091) 0
Proceeds from issuance of Company common stock 1,780 285
Tax benefits from stock-based compensation awards 0 875
Change in restricted cash (793) (368)
Other items (27) 0
Net cash provided by (used in) financing activities 23,950 (12,459)
Exchange Rate Effect on Cash and Cash Equivalents (1,195) (786)
(Decrease) Increase in Cash and Cash Equivalents (2,295) 10,764
Cash and Cash Equivalents at Beginning of Period 65,530 45,378
Cash and Cash Equivalents at End of Period $ 63,235 $ 56,142